Neutralization titers against omicron up with mRNA-1273 boost
Jan 28, 2022
After a mRNA-1273 (Moderna) boost, neutralization titers against the omicron variant were 20 times higher than than those at one month after second dose.
Remdesivir may benefit adults early in COVID-19 course
Jan 28, 2022
Real-world data support the use of remdesivir for hospitalized COVID-19 patients receiving no oxygen or low-flow oxygen.
Thrombosis, thrombocytopenia syndrome up after Ad26.COV2.S
Jan 28, 2022
Rates of 3.83 per million vaccine doses for Ad26.COV2.S (Johnson & Johnson) have been reported, versus 0.00855 per million for mRNA-based vaccines such as Pfizer-BioNTech and Moderna.
SENIOR Act proposes $10B sustainability fund, workforce development programs for assisted living
By
Kimberly Bonvissuto
Jan 28, 2022
Legislation to address labor challenges and create a sustainability fund to the tune of $1.25 billion for senior living providers is expected to be introduced today.
Enlivant first senior living provider awarded health, safety rating
By
Kimberly Bonvissuto
Jan 28, 2022
Enlivant is the first senior living provider to earn the WELL Health-Safety Rating for facility operations and management, the company announced Wednesday. The rating recognizes the entire portfolio...
Third mRNA vaccine dose ups effectiveness against hospitalization
Jan 27, 2022
Vaccine effectiveness against COVID-19 hospitalization is increased with a third dose in those with or without immunocompromising conditions.
Moderna begins testing booster shot aimed at omicron
Jan 27, 2022
The new study will focus on a single omicron-specific booster dose in about 600 adults.
Scientists watch, worry about new ‘stealth’ version of omicron variant
Jan 27, 2022
The variant, called BA.2, has genetic traits that make it somewhat more difficult to detect.
Omicron linked to increase in COVID-19 cases, lower disease severity
Jan 27, 2022
The mean length of stay and percentages admitted to the ICU, receiving invasive mechanical ventilation and dying were lower during omicron.
Alterations in gut microbiome ID’d in postacute COVID-19 syndrome
Jan 27, 2022
Higher levels of Ruminococcus gnavus, Bacteroides vulgatus, and lower levels of Faecalibacterium prausnitzii were observed in patients with PACS.